Codiak Biosciences

Developer of exosome-based drugs and diagnostics for cancer treatment

placeCambridge, Massachusetts, United States calendar_todayFounded 2015 groups48 employees language codiakbio.com

Registered entities

Innovation

61 patent families (7 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing, Operations & transport; filing pace slowing. Cited 4,825 times.

YearFilings
20141
20151
20162
20172
20185
201913
202023
202141
202235
202326
20243
20252

Investor mix

12 investors on record; lead investors include Arch Venture Partners, Flagship Pioneering.

Investor typeCountShare
Venture capital542%
Private equity217%
Other / undisclosed542%
Coming soon